SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,336.45 332.63
( 0.45%)

Global Indices

Nasdaq

52,102.03 -340.17
(-0.65%)

Dow Jones

7,605.54 -35.44
(-0.46%)

Hang Seng

63,783.20 299.10
(0.47%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.28 -0.19
(-0.20%)

EUR-INR

110.09 -0.64
(-0.57%)

GBP-INR

128.59 -0.52
(-0.40%)

JPY-INR

0.62 0.00
(-0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

16.45

14669.1

EPS(TTM)

Face Value()

Div & Yield %

49.8

0.61

Back

yaan enterprises ltd

Redington consolidated net profit rises 76.55% in the June 2026 quarter

Jul 30,2026

Net profit of Redington rose 76.55% to Rs 485.98 crore in the quarter ended June 2026 as against Rs 275.27 crore during the previous quarter ended June 2025. Sales rose 34.57% to Rs 34922.47 crore in the quarter ended June 2026 as against Rs 25951.99 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	34922.47	25951.99	35
OPM %	2.03	1.54	-
PBDT	661.57	358.15	85
PBT	610.87	304.33	101
NP	485.98	275.27	77

74,336.45 332.63 ( 0.45%)

52,102.03 -340.17 (-0.65%)

7,605.54 -35.44 (-0.46%)

63,783.20 299.10 (0.47%)

10,654.59 -42.98 (-0.40%)

95.28 -0.19 (-0.20%)

110.09 -0.64 (-0.57%)

128.59 -0.52 (-0.40%)

0.62 0.00 (-0.70%)